The use of subcutaneous natural ghrelin to treat cachexia (CC)-related symptom distress, nutritional intake (NI), and physical functioning: A two-step phase I/II study with an intrapatient dose escalation followed by maintenance treatment.
F. Strasser
No relevant relationships to disclose
D. Blum
No relevant relationships to disclose
R. Oberholzer
No relevant relationships to disclose
S. deWolf-Linder
No relevant relationships to disclose
C. Driessen
No relevant relationships to disclose
T. Cerny
No relevant relationships to disclose